![](/img/cover-not-exists.png)
THU0527 Lesinurad, A Selective Uric Acid Reabsorption Inhibitor, in Combination with Xanthane Oxidase Inhibitors: SUA and Flares Composite Endpoint from Phase III Studies in Gout Patients (Clear 1, Clear 2 and Crystal)
Khanna, P.P., Baumgartner, S., Robinson, J., Tafesse, E., Morlock, R.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.4488
Date:
June, 2016
File:
PDF, 83 KB
english, 2016